Related Experiment Video

Updated: Jul 25, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Macrolide antibiotics and pulmonary inflammation

J C Hoyt1, R A Robbins

  • 1Research Service, Building 52 (0-151), Southern Arizona VA Health Care System and Respiratory Sciences, University of Arizona, 3601 South 6th Avenue, Tucson, AZ 85723, USA. jeff.hoyt@med.va.gov

FEMS Microbiology Letters
|December 1, 2001
PubMed

Insights

Macrolide antibiotics, like erythromycin, possess anti-inflammatory properties beyond their antibacterial effects. These properties are beneficial for treating airway diseases such as asthma and diffuse panbronchiolitis.

Area of Science:

  • Pharmacology
  • Immunology
  • Respiratory Medicine

Background:

  • Therapeutic agents can have unintended effects beyond their primary pharmacological action.
  • Macrolide antibiotics, including erythromycin, exhibit anti-inflammatory activity distinct from their antibacterial function.
  • This anti-inflammatory activity is relevant in airway diseases like asthma and diffuse panbronchiolitis.

Purpose of the Study:

  • To review recent research on the anti-inflammatory activities of macrolide antibiotics.
  • To summarize the physiological, cellular, and molecular mechanisms underlying this effect.
  • To highlight the clinical relevance of these findings in airway diseases.

Main Methods:

  • Literature review of recent scientific studies.
  • Analysis of research on macrolide antibiotic mechanisms.
  • Synthesis of findings related to inflammatory processes.

Main Results:

  • Macrolide antibiotics demonstrate significant anti-inflammatory effects in airway diseases.
  • Erythromycin derivatives have shown clinical benefits in asthma and diffuse panbronchiolitis.
  • Understanding of molecular and cellular pathways inhibited by these compounds has advanced.

Conclusions:

  • The anti-inflammatory properties of macrolide antibiotics are a significant area of research.
  • These distinct actions offer therapeutic potential beyond traditional antibacterial use.
  • Further investigation into these mechanisms could lead to novel treatment strategies for inflammatory airway conditions.

More Related Videos

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...